Treatment of hormone-refractory prostate cancer with docetaxel or mitoxantrone: Relationships between prostate-specific antigen, pain and quality of life response and survival in the TAX-327 study

D Berthold; G Pond; M Roessner; R de Wit; M Eisenberger; I Tannock; Pirkko-Liisa Kellokumpu-Lehtinen

doi:10.1158/1078-0432.ccr-07-0944

Treatment of hormone-refractory prostate cancer with docetaxel or mitoxantrone: Relationships between prostate-specific antigen, pain and quality of life response and survival in the TAX-327 study

D Berthold, G Pond, M Roessner, R de Wit, M Eisenberger, I Tannock, Pirkko-Liisa Kellokumpu-Lehtinen

Research output: Contribution to journal › Article › Scientific › peer-review

175 Citations (Scopus)

Original language	English
Pages (from-to)	2763-2767
Journal	Clin Cancer Res
Volume	14
Issue number	9
DOIs	https://doi.org/10.1158/1078-0432.ccr-07-0944
Publication status	Published - 2008
Publication type	A1 Journal article-refereed

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1158/1078-0432.ccr-07-0944

Cite this

Berthold, D., Pond, G., Roessner, M., de Wit, R., Eisenberger, M., Tannock, I., & Kellokumpu-Lehtinen, P.-L. (2008). Treatment of hormone-refractory prostate cancer with docetaxel or mitoxantrone: Relationships between prostate-specific antigen, pain and quality of life response and survival in the TAX-327 study. Clin Cancer Res, 14(9), 2763-2767. https://doi.org/10.1158/1078-0432.ccr-07-0944

@article{0de88b50270c4b329de5d1780fed9081,

title = "Treatment of hormone-refractory prostate cancer with docetaxel or mitoxantrone: Relationships between prostate-specific antigen, pain and quality of life response and survival in the TAX-327 study",

author = "D Berthold and G Pond and M Roessner and {de Wit}, R and M Eisenberger and I Tannock and Pirkko-Liisa Kellokumpu-Lehtinen",

year = "2008",

doi = "10.1158/1078-0432.ccr-07-0944",

language = "English",

volume = "14",

pages = "2763--2767",

number = "9",

}

Berthold, D, Pond, G, Roessner, M, de Wit, R, Eisenberger, M, Tannock, I & Kellokumpu-Lehtinen, P-L 2008, 'Treatment of hormone-refractory prostate cancer with docetaxel or mitoxantrone: Relationships between prostate-specific antigen, pain and quality of life response and survival in the TAX-327 study', Clin Cancer Res, vol. 14, no. 9, pp. 2763-2767. https://doi.org/10.1158/1078-0432.ccr-07-0944

Treatment of hormone-refractory prostate cancer with docetaxel or mitoxantrone: Relationships between prostate-specific antigen, pain and quality of life response and survival in the TAX-327 study. / Berthold, D; Pond, G; Roessner, M et al.
In: Clin Cancer Res, Vol. 14, No. 9, 2008, p. 2763-2767.

Research output: Contribution to journal › Article › Scientific › peer-review

TY - JOUR

T1 - Treatment of hormone-refractory prostate cancer with docetaxel or mitoxantrone: Relationships between prostate-specific antigen, pain and quality of life response and survival in the TAX-327 study

AU - Berthold, D

AU - Pond, G

AU - Roessner, M

AU - de Wit, R

AU - Eisenberger, M

AU - Tannock, I

AU - Kellokumpu-Lehtinen, Pirkko-Liisa

PY - 2008

Y1 - 2008

U2 - 10.1158/1078-0432.ccr-07-0944

DO - 10.1158/1078-0432.ccr-07-0944

M3 - Article

SN - 1078-0432

VL - 14

SP - 2763

EP - 2767

JO - Clin Cancer Res

JF - Clin Cancer Res

IS - 9

ER -